The orthopedic implants market encompasses a wide range of device types, primarily categorized into internal fixation devices and external fixation devices. Internal fixation devices are designed to be implanted inside the body, offering stability to fractured bones or damaged joints. These include screws, plates, and rods. In contrast, external fixation devices such as external frames and pins are applied externally to immobilize and support the injured area. This segmentation provides surgeons with diverse tools to address various orthopedic conditions effectively.
Access Full Report @ https://www.databridgemarketresearch.com/reports/asia-pacific-orthopedic-implants-market
Data Bridge Market Research analyses that the Asia-Pacific Orthopedic Implants Market, which was USD 4,893.65 million in 2022, is expected to reach USD 7,978.09 million by 2030 and is expected to undergo a CAGR of 6.30% during the forecast period of 2023 to 2030. Increased participation in sports activities exposes individuals to a higher risk of orthopedic injuries, such as fractures and ligament damage. These injuries often necessitate orthopedic implants, contributing to the demand in the orthopedic implants market.
Key Findings of the Study
The aging population is expected to drive the market's growth rate
The growing elderly population is a significant driver of orthopedic implant procedures. With age, individuals become more susceptible to orthopedic conditions such as joint arthritis, which can result in pain and reduced mobility. Implants, such as joint replacements, offer a viable solution to alleviate discomfort and enhance the quality of life in elderly patients. As the aging demographic expands, the demand for orthopedic implants increases, driving growth in the orthopedic implants market.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Products (Reconstructive Joint Replacements, Spinal Implants, Trauma and Craniomaxillofacial, Dental Implants, and Orthobiologics), Device Type (Internal Fixation Devices and External Fixation Devices), Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials, and Others), Procedures (Open Surgery, Minimally Invasive Surgery (MIS)), End Users (Hospitals, Ambulatory Care Center, Specialized Clinics, Orthopedic Centers, and Others)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
|
|
Market Players Covered
|
Zimmer Biomet (U.S.), Smith & Nephew plc (U.K.), Medtronic (Ireland), Stryker (U.S.), Braun Melsungen AG (Germany), NuVasive, Inc. (U.S.), DJO, LLC (U.S.), Institut Straumann AG (Switzerland), OSSTEM IMPLANT CO., LTD. (South Korea), Narang Medical Limited (U.S.), Globus Medical (U.S.), Arthrex, Inc. (U.S.), CONMED Corporation (U.S.), Integra LifeSciences Corporation (U.S.), RTI Surgical (U.S.), W. L. Gore & Associates, Inc. (U.S.), Corin Group (U.K.), Johnson & Johnson Services, Inc. (U.S.)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The Asia-Pacific orthopedic implants market is segmented on the basis of product, device type, biomaterial, procedures, and end users.
- On the basis of product, the Asia-Pacific orthopedic implants market is segmented into reconstructive joint replacements, spinal implants, trauma and craniomaxillofacial, dental implants, and orthobiologics.
- On the basis of device type, the Asia-Pacific orthopedic implants market is segmented into internal fixation devices and external fixation devices.
- On the basis of biomaterial, the Asia-Pacific orthopedic implants market is segmented into metallic biomaterials, polymeric biomaterials, ceramic biomaterials, natural biomaterials, and others.
- On the basis of procedures, the Asia-Pacific orthopedic implants market is segmented into open surgery, and minimally invasive Surgery (MIS).
- On the basis of end users, the Asia-Pacific orthopedic implants market is segmented into hospitals, ambulatory care center, specialized clinics, orthopedic centers, and others.
Major Players
Data Bridge Marke Asia-Pacific orthopedic implants market Asia-Pacific data center construction market players in Asia-Pacific orthopedic implants market are Zimmer Biomet (U.S.), Smith & Nephew plc (U.K.), Medtronic (Ireland), Stryker (U.S.), Braun Melsungen AG (Germany), NuVasive, Inc. (U.S.), DJO, LLC (U.S.), Institut Straumann AG (Switzerland), OSSTEM IMPLANT CO., LTD. (South Korea).
Market Developments
- In September 2020, Smith & Nephew plc launched its REDAPT System for revision total hip arthroplasty (rTHA) in the Chinese market. This innovative product significantly bolstered the company's sales and demand in Asia-Pacific. By introducing a high-quality solution for hip revision surgery, Smith & Nephew addressed the growing medical needs in the region, gaining a stronger foothold in the market and reinforcing its commitment to advancing orthopedic healthcare in Asia.
- In April 2022, the Orthopaedic Implant Company received FDA approval for its dorsal spanning plate, an essential addition to its product portfolio. This approval broadens their range of offerings and enhances the utility of their previously launched DRPx, a distal radius plating system available in the U.S. It signifies the company's commitment to providing comprehensive orthopedic solutions and addressing the diverse needs of the medical community and patients.
- In January 2021, GOeasy, a prominent player in the orthopedic implants industry, announced its collaboration with PeekMed, a leading software technology company specializing in a powerful 3D preoperative planning platform. This collaboration allows orthopedic professionals to enhance joint replacement procedures by integrating digital planning tools. By joining forces, GOeasy and PeekMed are poised to offer cutting-edge, technology-driven solutions that can improve the precision and outcomes of orthopedic surgeries.
Regional Analysis
Geographically, the countries covered in the Asia-Pacific orthopedic implants market report China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
As per Data Bridge Market Research analysis:
China is the dominant region in Asia-Pacific orthopedic implants market during the forecast period 2023-2030
China dominates the Asia-Pacific orthopedic implants market, driven by its expanding senior population. As the number of elderly individuals in the region grows, so does the demand for reconstructive joint replacements. This demographic shift, coupled with increasing awareness and access to healthcare, positions China as a prominent hub for orthopedic implant procedures, contributing to the market's significant growth in the Asia-Pacific region.
India is estimated to be the fastest-growing region Asia-Pacific orthopedic implants market in the market the forecast period 2023-2030
India is projected to experience the highest compound annual growth rate (CAGR) in the Asia-Pacific orthopedic implants market from 2023 to 2030. This growth is attributed to the increasing incidence of musculoskeletal and orthopedic injuries. As India's population becomes more active and healthcare infrastructure improves, the demand for orthopedic implants is expected to surge, making it a key driver of market expansion in the region during the forecast period.
For more detailed information about the Asia-Pacific orthopedic implants market report, click here – https://www.databridgemarketresearch.com/reports/asia-pacific-orthopedic-implants-market
